Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 8/20 | 1.00 |
| ▸ | CYP11B2 | P19099 | 8/20 | 1.00 |
| ▸ | TNF | P01375 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 5/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31357411 | 1.00 | CYP11B1 (1.00) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL13907295 | 0.94 | CYP11B1 (0.89) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL28610944 | 0.92 | CYP11B1 (0.84) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| Piperazine SCHEMBL7388680 | 0.90 | CYP11B1 (0.81) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL9049676 | 0.90 | CYP11B1 (1.00) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL31722842 | 0.89 | CYP11B1 (0.80) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL3177643 | 0.89 | CYP11B1 (0.80) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL8325011 | 0.87 | CYP11B1 (0.77) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL15551049 | 0.87 | CYP11B1 (0.77) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 | |
| SCHEMBL14042406 | 0.87 | CYP11B1 (1.00) | CYP11B1CYP11B2TNFHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117946141-A | Low-cost metal organic fluorescent material for high-power LED illumination | 常州大学 | 2024-04-30 | — | — | CN | claimed |
| CN-115850345-A | Quinoline functional nitrogen heterocyclic carbene ruthenium complex with multiple anti-cancer activities and preparation method thereof | 浙江树人学院 | 2023-03-28 | — | — | CN | claimed |
| CN-113004206-B | Naphthalene derivative fluorescent probe and preparation method and application thereof | 齐齐哈尔大学 | 2022-06-17 | — | — | CN | claimed |
| CN-113004206-A | Naphthalene derivative fluorescent probe and preparation method and application thereof | 齐齐哈尔大学 | 2021-06-22 | — | — | CN | claimed |
| CN-105921116-B | Cation with immixture pattern exchanges Solid Phase Extraction material and its preparation method and application | 中国烟草总公司郑州烟草研究院 | 2018-10-09 | — | — | CN | claimed |
| CN-106117147-B | Miscellaneous tall and erect class compound of naphtho- and the preparation method and application thereof | 天津师范大学 | 2018-10-02 | — | — | CN | claimed |
| CN-106117147-A | Miscellaneous tall and erect compounds of naphtho-and preparation method and application | 天津师范大学 | 2016-11-16 | — | — | CN | claimed |
| CN-105921116-A | Cation exchange solid-phase extraction material with mixing effect mode and preparation method and application thereof | 中国烟草总公司郑州烟草研究院 | 2016-09-07 | — | — | CN | claimed |
| CN-102173010-A | Benzimidazole ionic liquid aid used in rubber processing and preparation method thereof | UNIV FUJIAN | 2011-09-07 | — | — | CN | claimed |
| CN-101503392-A | Aromatic aminomethane compounds, as well as preparation and medical use thereof | UNIV CHINA PHARMA (CN) | 2009-08-12 | — | — | CN | claimed |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-03-06 | — | — | US | claimed |
| WO-2004078874-A2 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | POLAROID CORPORATION (US) | 2004-09-16 | — | — | WO | claimed |
| US-20040171817-A1 | Novel dye complexes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-02 | — | — | US | claimed |
| EP-0628549-B1 | New 1-phenylmethyl benzimidazole piperazine derivatives | ESPANOLA DE PRODUCTOS FAB (ES) | 2000-12-06 | — | — | EP | claimed |
| EP-0428260-A2 | Metal surface treatment agents | SANWA LABORATORY LTD. (JP) | 1991-05-22 | — | — | EP | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |
| US-4542394-A | MULTILAYER-DIAZONIUM LAYER AND COUPLER LAYER CONTAINING BENZIMIDAZOLE COMPOUND | RICOH COMPANY, LTD. (JP) | 1985-09-17 | — | — | US | claimed |
| US-20260015339-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | UNIVERSITE GRENOBLE ALPES (FR) | 2026-01-15 | — | — | US | disclosed |
| US-4542394-A | MULTILAYER-DIAZONIUM LAYER AND COUPLER LAYER CONTAINING BENZIMIDAZOLE COMPOUND | RICOH COMPANY, LTD. (JP) | 1985-09-17 | — | — | US | disclosed |
| US-4460709-A | Process for producing oxygen-containing organic compounds | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1984-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015339-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | CBR1, CYP4X1, CBR3 | CYP11B1 348/4885CYP11B2 362/4885TNF 4529/4885 |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | DBI, HSPE1, ABCB7 | CYP11B1 983/4885CYP11B2 1148/4885TNF 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.